Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137767) titled 'Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: TECLens, Inc.
Condition:
Presbyopia
Intervention:
Device: Quantitative refractive crosslinking
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 31, 2025
Target Sample Size: 25
Countries of Recruitment:
Brazil
Dominican Republic
Brazil
Dominican Republic
To know more, visit...